Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALL-MB 2015 Protocol for Acute Lymphoblastic Leukemia
NCT03390387Phase 3Unknown
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Nov 2015
- Primary completion
- Nov 2020
- Modality
- Modified Peptides, Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of bortezomib, idarubicin, methylprednisolone injection, dexamethasone in acute lymphoblastic leukemia (ALL), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Status: unknown.
02
Drugs
bortezomibidarubicinmethylprednisolone injectiondexamethasone
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03390387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03390387.